REmote SUpervision to Decrease HospitaLization RaTe. Unified and integrated platform for data collected from devices...

Area of Science:

• Cardiology
• Biomedical Engineering
• Health Informatics

Background:

• The population with implantable cardiac electronic devices (CIEDs) for heart failure is increasing, leading to high hospitalization rates and costs.
• Current remote monitoring (RM) for CIEDs faces challenges due to system variability and data loss, limiting comprehensive analysis.
• Existing studies on RM effectiveness often focus on single-company devices, hindering broader clinical application.

Purpose of the Study:

• To evaluate the impact of RM using an integrated platform on the clinical status of patients with implantable cardioverter-defibrillators (ICDs) or cardiac resynchronization therapy defibrillators (CRT-Ds).
• To assess the safety, feasibility, and efficacy of a unified RM platform integrating data from various device manufacturers.
• To determine if RM via an integrated platform can decrease hospitalization rates in CIED patients.

Main Methods:

• A prospective, randomized trial (RESULT study) involving 600 consecutive patients with ICDs or CRT-Ds.
• Patients will be randomized to either traditional follow-up or RM-based follow-up using an integrated platform.
• The primary clinical endpoint is a composite of all-cause mortality or cardiovascular hospitalization within 12 months; the primary technical endpoint is the platform's evaluation.

Main Results:

• This manuscript details the study design and methodology.
• The trial aims to establish the clinical and technical performance of an integrated RM platform.
• Results will provide insights into the effectiveness of multi-vendor RM in managing CIED patients.

Conclusions:

• An integrated RM platform may offer a more comprehensive approach to managing CIED patients.
• This approach has the potential to improve clinical outcomes and reduce healthcare costs associated with CIED management.
• The study will determine the efficacy of this novel RM strategy in reducing hospitalizations.